Correlation Between Genomma Lab and Blueberries Medical

Can any of the company-specific risk be diversified away by investing in both Genomma Lab and Blueberries Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genomma Lab and Blueberries Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genomma Lab Internacional and Blueberries Medical Corp, you can compare the effects of market volatilities on Genomma Lab and Blueberries Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genomma Lab with a short position of Blueberries Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genomma Lab and Blueberries Medical.

Diversification Opportunities for Genomma Lab and Blueberries Medical

-0.44

Correlation Coefficient

Genomma Lab  Blueberries Medical

Very good diversification

The 3 months correlation between Genomma and Blueberries is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Genomma Lab Internacional and Blueberries Medical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueberries Medical Corp and Genomma Lab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genomma Lab Internacional are associated (or correlated) with Blueberries Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueberries Medical Corp has no effect on the direction of Genomma Lab i.e., Genomma Lab and Blueberries Medical go up and down completely randomly.

Pair Corralation between Genomma Lab and Blueberries Medical

Assuming the 90 days horizon Genomma Lab Internacional is expected to generate 0.16 times more return on investment than Blueberries Medical. However, Genomma Lab Internacional is 6.32 times less risky than Blueberries Medical. It trades about 0.17 of its potential returns per unit of risk. Blueberries Medical Corp is currently generating about 0.0 per unit of risk. If you would invest  107.00  in Genomma Lab Internacional on September 12, 2024 and sell it today you would earn a total of  20.00  from holding Genomma Lab Internacional or generate 18.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Genomma Lab Internacional  vs.  Blueberries Medical Corp

Genomma Lab Internacional

Risk-Adjusted Performance

13 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Genomma Lab Internacional are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Genomma Lab reported solid returns over the last few months and may actually be approaching a breakup point.

Blueberries Medical Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Blueberries Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Blueberries Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Genomma Lab and Blueberries Medical

The main advantage of trading using opposite Genomma Lab and Blueberries Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genomma Lab position performs unexpectedly, Blueberries Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueberries Medical will offset losses from the drop in Blueberries Medical's long position.

The idea behind Genomma Lab Internacional and Blueberries Medical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.